세계의 제세동기 시장 : 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

Defibrillator Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

US $ 4,995 ￦ 6,879,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,046,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,699,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

제세동기 시장 보고서는 2024년부터 2032년까지 주요 역학, 성장 요인, 도전 과제, 새로운 동향 등을 포괄하는 업계의 상세한 분석을 제공합니다. 이 보고서는 세계의 제세동기 시장의 현재 시나리오와 예측에 대한 통찰력을 제공합니다.

세계의 제세동기 시장은 2024년 122억 달러에서 연평균(CAGR) 7.4%로 성장해 2032년 249억 달러에 달할 것으로 예상됩니다.

주요 인사이트

• 추정 시장 규모(2024년) : 122억 달러
• 2032년 예상 시장 규모 : 249억 달러
• 세계 시장 성장률(2024-2032년 CAGR) : 7.4%

제세동기 시장 : 조사 범위

제세동기는 갑작스런 심장마비(SCA)를 치료하는 데 사용되는 중요한 의료기기입니다. 치료용 양의 전기 에너지를 환부의 심장에 공급합니다. 이 보고서는 제세동기 수요를 촉진하는 주요 요인으로 심혈관 질환 발병률 증가, 조기 제세동의 중요성에 대한 대중의 인식 증가, 제세동기 기술 발전 등을 꼽고 있습니다.

시장 성장의 촉진요인

제세동기 시장의 성장에는 여러 가지 요인이 기여하고 있습니다. 주요 촉진요인은 갑작스러운 심장마비의 위험을 증가시키는 심혈관 질환의 전 세계 유병률 증가입니다. 또한 공항, 학교, 스포츠 경기장 등 공공장소에 자동심장충격기(AED)를 설치하는 공공 접근 제세동 프로그램이 확대되고 있는 것도 큰 성장 동력이 되고 있습니다. 제세동기를 보다 쉽고 효과적으로 사용할 수 있도록 하는 기술의 발전도 시장 확대에 힘을 보태고 있습니다. 또한, 비의료인에게 AED 사용법을 교육하기 위한 정부의 이니셔티브와 공공장소에서 제세동기 사용을 의무화하는 엄격한 규제 시행도 시장 성장을 가속하고 있습니다.

시장 성장 억제요인

전망은 밝지만, 제세동기 시장은 문제에 직면해 있습니다. 고급 제세동기 시스템과 관련된 높은 비용은 특히 저개발 지역과 신흥 시장에서 시장 성장을 저해할 수 있습니다. 또한, 제세동기의 유지보수 및 교체에 대한 문제도 또 다른 도전과제로 작용하고 있습니다. 승인에 대한 규제 장벽과 기기 오작동 및 고장에 대한 우려도 시장 성장을 저해할 수 있습니다.

시장 기회

제세동기 시장에는 성장과 혁신을 위한 큰 기회가 있습니다. 주요 기회 중 하나는 환자의 요구에 더 잘 대응할 수 있는 보다 진보된 이식형 제세동기(ICD)와 웨어러블 제세동기의 개발에 있습니다. 농촌 지역이나 의료 서비스가 부족한 지역에 AED를 보급하는 것도 성장의 길입니다. 또한, 공공 기관과 민간 기업의 협력 관계를 강화하여 일반 대중의 인지도를 높이고 교육 프로그램을 강화하면 시장은 더욱 확대될 수 있습니다.

본 보고서에서 다룬 주요 질문들

• 2024년부터 2032년까지 제세동기 세계 시장의 예상 CAGR은?
• 제세동기 시장의 성장을 가속하는 주요 요인은?
• 제세동기 시장에서 가장 큰 시장 점유율을 차지하는 제품 유형은?
• 세계의 제세동기 시장의 주요 기업은?
• 제세동기 시장에서 경쟁을 유지하기 위해 주요 기업들은 어떤 전략을 채택하고 있는가?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한

제3장 시장 배경

• 시장 역학
• 시나리오 예측
• 기회 맵 분석
• 제품수명주기 분석
• 공급망 분석
• 투자 실현 가능성 매트릭스
• 밸류체인 분석
• PESTLE와 Porter's Five Forces 분석
• 규제 상황
• 지역 모시장 전망
• 생산·소비 통계
• 수입과 수출 통계

제4장 세계의 제세동기 시장 분석

• 과거 시장 규모(금액 및 수량) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액 및 수량) 예측, 2024-2032년

제5장 세계의 제세동기 시장 분석 : 제품 유형별

• 서론/주요 조사 결과
• 과거 시장 규모(금액 및 수량) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액 및 수량) 분석 및 예측, 2024-2032년
  • 삽입형 제세동기(ICD)
    • S-ICD
    • T-ICD
  • 체외식 제세동기(ED)
    • 수동 ED
    • 자동 ED
    • 웨어러블 제세동기
• 전년대비 성장 동향 분석, 2019-2023년
• 절대적 매출 기회 분석, 2024-2032년

제6장 세계의 제세동기 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모(금액 및 수량) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액 및 수량) 분석 및 예측, 2024-2032년
  • 병원
  • 병원 전
  • 공공 액세스 시장
  • 대체 의료 시장
  • 재택 헬스케어
• 전년대비 성장 동향 분석, 2019-2023년
• 절대적 매출 기회 분석, 2024-2032년

제7장 세계의 제세동기 시장 분석 : 지역별

• 서론
• 과거 시장 규모(금액 및 수량) 분석, 2019-2023년
• 현재 시장 규모(금액 및 수량) 분석 및 예측, 2024-2032년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카
• 지역별 시장의 매력 분석

제8장 북미의 제세동기 시장 분석(국가별)

제9장 라틴아메리카의 제세동기 시장 분석(국가별)

제10장 유럽의 제세동기 시장 분석(국가별)

제11장 동아시아의 제세동기 시장 분석(국가별)

제12장 남아시아의 제세동기 시장 분석(국가별)

제13장 오세아니아의 제세동기 시장 분석(국가별)

제14장 중동 및 아프리카의 제세동기 시장 분석(국가별)

제15장 주요 국가 제세동기 시장 분석

• 미국
• 캐나다
• 브라질
• 멕시코
• 아르헨티나
• 독일
• 이탈리아
• 프랑스
• 영국
• 스페인
• 러시아
• 베네룩스
• 중국
• 일본
• 한국
• 인도
• 태국
• 말레이시아
• 인도네시아
• 호주
• 뉴질랜드
• GCC 국가

제16장 시장 구조 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 주요 기업의 시장 점유율 분석

제17장 경쟁 분석

• 경쟁 상세
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Stryker
  • Zoll Medical Corporation
  • Biotronik
  • Nihon Kohden Corporation
  • METRAWATT International
  • Datrend Systems
  • Fluke
  • BC Group International
  • Netech

제18장 사용된 전제조건과 두자어

제19장 조사 방법

LSH

영문 목차

영문목차

The Defibrillator Market report provides a detailed analysis of the industry, covering key dynamics, growth factors, challenges, and emerging trends for the period from 2024 to 2032. This report offers insights into the current scenario and future projections of the global defibrillator market.

The global defibrillator market is projected to grow at a compound annual growth rate (CAGR) of 7.4% from USD 12.2 billion in 2024 to USD 24.9 billion by 2032.

Key Insights:

• Estimated Market Size (2024): USD 12.2 Billion
• Projected Market Size (2032): USD 24.9 Billion
• Global Market Growth Rate (CAGR 2024 to 2032): 7.4%

Defibrillator Market - Report Scope:

Defibrillators are critical medical devices used in the treatment of sudden cardiac arrest (SCA). They deliver a therapeutic dose of electrical energy to the affected heart. The report outlines key drivers of demand for defibrillators, including increasing incidence of cardiovascular diseases, growing public awareness about the importance of early defibrillation in saving lives, and advancements in defibrillator technology.

Market Growth Drivers:

Several factors contribute to the growth of the defibrillator market. The primary driver is the rising prevalence of cardiovascular diseases globally, which increases the risk of sudden cardiac arrest. Additionally, the expansion of public access defibrillation programs, which involve placing automated external defibrillators (AEDs) in public spaces like airports, schools, and sports arenas, is another significant growth driver. Technological advancements in defibrillators, making them more user-friendly and effective, also support market expansion. Furthermore, government initiatives to train non-medical personnel in the use of AEDs and the implementation of stringent regulations mandating the availability of defibrillators in public places enhance market growth.

Market Restraints:

Despite the positive outlook, the defibrillator market faces challenges. High costs associated with advanced defibrillator systems can hinder market growth, particularly in underdeveloped and developing regions. Also, issues related to the maintenance and replacement of these devices pose additional challenges. Regulatory hurdles for approval and concerns about device malfunction or failure can also impede market growth.

Market Opportunities:

The defibrillator market offers significant opportunities for growth and innovation. One major opportunity lies in the development of more sophisticated implantable cardioverter defibrillators (ICDs) and wearable defibrillator devices that can better cater to patient needs. Expanding the reach of AEDs into rural and underserved areas presents another growth avenue. Additionally, increasing collaborations between public organizations and private companies to enhance public awareness and training programs can further expand the market.

Key Questions Addressed in the Report:

• What is the Expected CAGR of the Global Defibrillator Market from 2024 to 2032?
• What are the Key Factors Driving the Growth of the Defibrillator Market?
• Which Product Type Holds the Largest Market Share in the Defibrillator Market?
• Who are the Key Players in the Global Defibrillator Market?
• What Strategies are Adopted by Leading Companies to Stay Competitive in the Defibrillator Market?

Competitive Landscape and Business Strategies:

The key players in the Defibrillator Market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Koninklijke Philips N.V., and ZOLL Medical Corporation, among others. These companies focus on innovation, such as integrating advanced monitoring technologies with defibrillators, to maintain their market position. Strategic partnerships and acquisitions are also commonly pursued to expand product lines and geographic presence.

Key Companies Profiled

• Medtronic
• Abbott
• Boston Scientific Corporation
• Stryker
• Zoll Medical Corporation
• Biotronik
• Nihon Kohden Corporation
• METRAWATT International
• Datrend Systems
• Fluke
• BC Group International
• Netech

Market Segments Covered in Defibrillator Market Analysis

By Component

• Implantable Cardioverter Defibrillators (ICD)
• External Defibrillators (ED)

By Type

• S-ICD
• T-ICD
• Manual ED
• Automated ED
• Wearable Cardioverter Defibrillators

By End Use

• Hospital
• Pre Hospital
• Public Access Market
• Alternate Care Market
• Home Healthcare

By Region

• North America
• Latin America
• Europe
• APAC
• MEA

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Product Life Cycle Analysis
• 3.5. Supply Chain Analysis
  • 3.5.1. Supply Side Participants and their Roles
    • 3.5.1.1. Producers
  • 3.5.2. Value Added and Value Created at Node in the Supply Chain
  • 3.5.3. List of Existing and Potential Buyer's
• 3.6. Investment Feasibility Matrix
• 3.7. Value Chain Analysis
  • 3.7.1. Profit Margin Analysis
• 3.8. PESTLE and Porter's Analysis
• 3.9. Regulatory Landscape
  • 3.9.1. By Key Regions
  • 3.9.2. By Key Countries
• 3.10. Regional Parent Market Outlook
• 3.11. Production and Consumption Statistics
• 3.12. Import and Export Statistics

4. Global Defibrillator Market Analysis 2019-2023 and Forecast, 2024-2032

• 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2024-2032
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2019-2023
• 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2024-2032
  • 5.3.1. Implantable Cardioverter Defibrillators (ICD)
    • 5.3.1.1. S-ICD
    • 5.3.1.2. T-ICD
  • 5.3.2. External Defibrillators (ED)
    • 5.3.2.1. Manual ED
    • 5.3.2.2. Automated ED
    • 5.3.2.3. Wearable Cardioverter Defibrillators
• 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032

6. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By End User

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2024-2032
  • 6.3.1. Hospital
  • 6.3.2. Pre Hospital
  • 6.3.3. Public Access Market
  • 6.3.4. Alternate Care Market
  • 6.3.5. Home Healthcare
• 6.4. Y-o-Y Growth Trend Analysis By End User, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By End User, 2024-2032

7. Global Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Region

• 7.1. Introduction
• 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2023
• 7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2024-2032
  • 7.3.1. North America
  • 7.3.2. Latin America
  • 7.3.3. Europe
  • 7.3.4. East Asia
  • 7.3.5. South Asia
  • 7.3.6. Oceania
  • 7.3.7. MEA
• 7.4. Market Attractiveness Analysis By Region

8. North America Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 8.2.1. By Country
    • 8.2.1.1. U.S.
    • 8.2.1.2. Canada
  • 8.2.2. By Product Type
  • 8.2.3. By End User
• 8.3. Market Attractiveness Analysis
  • 8.3.1. By Country
  • 8.3.2. By Product Type
  • 8.3.3. By End User
• 8.4. Key Takeaways

9. Latin America Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 9.2.1. By Country
    • 9.2.1.1. Brazil
    • 9.2.1.2. Mexico
    • 9.2.1.3. Argentina
    • 9.2.1.4. Rest of Latin America
  • 9.2.2. By Product Type
  • 9.2.3. By End User
• 9.3. Market Attractiveness Analysis
  • 9.3.1. By Country
  • 9.3.2. By Product Type
  • 9.3.3. By End User
• 9.4. Key Takeaways

10. Europe Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 10.2.1. By Country
    • 10.2.1.1. Germany
    • 10.2.1.2. Italy
    • 10.2.1.3. France
    • 10.2.1.4. U.K.
    • 10.2.1.5. Spain
    • 10.2.1.6. Russia
    • 10.2.1.7. BENELUX
    • 10.2.1.8. Rest of Europe
  • 10.2.2. By Product Type
  • 10.2.3. By End User
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Product Type
  • 10.3.3. By End User
• 10.4. Key Takeaways

11. East Asia Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 11.2.1. By Country
    • 11.2.1.1. China
    • 11.2.1.2. Japan
    • 11.2.1.3. South Korea
  • 11.2.2. By Product Type
  • 11.2.3. By End User
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Product Type
  • 11.3.3. By End User
• 11.4. Key Takeaways

12. South Asia Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 12.2.1. By Country
    • 12.2.1.1. India
    • 12.2.1.2. Thailand
    • 12.2.1.3. Malaysia
    • 12.2.1.4. Indonesia
    • 12.2.1.5. Rest of South Asia
  • 12.2.2. By Product Type
  • 12.2.3. By End User
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Product Type
  • 12.3.3. By End User
• 12.4. Key Takeaways

13. Oceania Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 13.2.1. By Country
    • 13.2.1.1. Australia
    • 13.2.1.2. New Zealand
  • 13.2.2. By Product Type
  • 13.2.3. By End User
• 13.3. Market Attractiveness Analysis
  • 13.3.1. By Country
  • 13.3.2. By Product Type
  • 13.3.3. By End User
• 13.4. Key Takeaways

14. MEA Defibrillator Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
• 14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2032
  • 14.2.1. By Country
    • 14.2.1.1. GCC
    • 14.2.1.2. Rest of MEA
  • 14.2.2. By Product Type
  • 14.2.3. By End User
• 14.3. Market Attractiveness Analysis
  • 14.3.1. By Country
  • 14.3.2. By Product Type
  • 14.3.3. By End User
• 14.4. Key Takeaways

15. Key Countries Defibrillator Market Analysis

• 15.1. U.S.
  • 15.1.1. Pricing Analysis
  • 15.1.2. Market Share Analysis, 2024
    • 15.1.2.1. By Product Type
    • 15.1.2.2. By End User
• 15.2. Canada
  • 15.2.1. Pricing Analysis
  • 15.2.2. Market Share Analysis, 2024
    • 15.2.2.1. By Product Type
    • 15.2.2.2. By End User
• 15.3. Brazil
  • 15.3.1. Pricing Analysis
  • 15.3.2. Market Share Analysis, 2024
    • 15.3.2.1. By Product Type
    • 15.3.2.2. By End User
• 15.4. Mexico
  • 15.4.1. Pricing Analysis
  • 15.4.2. Market Share Analysis, 2024
    • 15.4.2.1. By Product Type
    • 15.4.2.2. By End User
• 15.5. Argentina
  • 15.5.1. Pricing Analysis
  • 15.5.2. Market Share Analysis, 2024
    • 15.5.2.1. By Product Type
    • 15.5.2.2. By End User
• 15.6. Germany
  • 15.6.1. Pricing Analysis
  • 15.6.2. Market Share Analysis, 2024
    • 15.6.2.1. By Product Type
    • 15.6.2.2. By End User
• 15.7. Italy
  • 15.7.1. Pricing Analysis
  • 15.7.2. Market Share Analysis, 2024
    • 15.7.2.1. By Product Type
    • 15.7.2.2. By End User
• 15.8. France
  • 15.8.1. Pricing Analysis
  • 15.8.2. Market Share Analysis, 2024
    • 15.8.2.1. By Product Type
    • 15.8.2.2. By End User
• 15.9. U.K.
  • 15.9.1. Pricing Analysis
  • 15.9.2. Market Share Analysis, 2024
    • 15.9.2.1. By Product Type
    • 15.9.2.2. By End User
• 15.10. Spain
  • 15.10.1. Pricing Analysis
  • 15.10.2. Market Share Analysis, 2024
    • 15.10.2.1. By Product Type
    • 15.10.2.2. By End User
• 15.11. Russia
  • 15.11.1. Pricing Analysis
  • 15.11.2. Market Share Analysis, 2024
    • 15.11.2.1. By Product Type
    • 15.11.2.2. By End User
• 15.12. BENELUX
  • 15.12.1. Pricing Analysis
  • 15.12.2. Market Share Analysis, 2024
    • 15.12.2.1. By Product Type
    • 15.12.2.2. By End User
• 15.13. China
  • 15.13.1. Pricing Analysis
  • 15.13.2. Market Share Analysis, 2024
    • 15.13.2.1. By Product Type
    • 15.13.2.2. By End User
• 15.14. Japan
  • 15.14.1. Pricing Analysis
  • 15.14.2. Market Share Analysis, 2024
    • 15.14.2.1. By Product Type
    • 15.14.2.2. By End User
• 15.15. South Korea
  • 15.15.1. Pricing Analysis
  • 15.15.2. Market Share Analysis, 2024
    • 15.15.2.1. By Product Type
    • 15.15.2.2. By End User
• 15.16. India
  • 15.16.1. Pricing Analysis
  • 15.16.2. Market Share Analysis, 2024
    • 15.16.2.1. By Product Type
    • 15.16.2.2. By End User
• 15.17. Thailand
  • 15.17.1. Pricing Analysis
  • 15.17.2. Market Share Analysis, 2024
    • 15.17.2.1. By Product Type
    • 15.17.2.2. By End User
• 15.18. Malaysia
  • 15.18.1. Pricing Analysis
  • 15.18.2. Market Share Analysis, 2024
    • 15.18.2.1. By Product Type
    • 15.18.2.2. By End User
• 15.19. Indonesia
  • 15.19.1. Pricing Analysis
  • 15.19.2. Market Share Analysis, 2024
    • 15.19.2.1. By Product Type
    • 15.19.2.2. By End User
• 15.20. Australia
  • 15.20.1. Pricing Analysis
  • 15.20.2. Market Share Analysis, 2024
    • 15.20.2.1. By Product Type
    • 15.20.2.2. By End User
• 15.21. New Zealand
  • 15.21.1. Pricing Analysis
  • 15.21.2. Market Share Analysis, 2024
    • 15.21.2.1. By Product Type
    • 15.21.2.2. By End User
• 15.22. GCC Countries
  • 15.22.1. Pricing Analysis
  • 15.22.2. Market Share Analysis, 2024
    • 15.22.2.1. By Product Type
    • 15.22.2.2. By End User

16. Market Structure Analysis

• 16.1. Competition Dashboard
• 16.2. Competition Benchmarking
• 16.3. Market Share Analysis of Top Players
  • 16.3.1. By Regional
  • 16.3.2. By Product Type
  • 16.3.3. By End User

17. Competition Analysis

• 17.1. Competition Deep Dive
  • 17.1.1. Medtronic
    • 17.1.1.1. Overview
    • 17.1.1.2. Product Portfolio
    • 17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.1.4. Sales Footprint
    • 17.1.1.5. Strategy Overview
      • 17.1.1.5.1. Marketing Strategy
      • 17.1.1.5.2. Product Strategy
      • 17.1.1.5.3. Channel Strategy
  • 17.1.2. Abbott
    • 17.1.2.1. Overview
    • 17.1.2.2. Product Portfolio
    • 17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.2.4. Sales Footprint
    • 17.1.2.5. Strategy Overview
      • 17.1.2.5.1. Marketing Strategy
      • 17.1.2.5.2. Product Strategy
      • 17.1.2.5.3. Channel Strategy
  • 17.1.3. Boston Scientific Corporation
    • 17.1.3.1. Overview
    • 17.1.3.2. Product Portfolio
    • 17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.3.4. Sales Footprint
    • 17.1.3.5. Strategy Overview
      • 17.1.3.5.1. Marketing Strategy
      • 17.1.3.5.2. Product Strategy
      • 17.1.3.5.3. Channel Strategy
  • 17.1.4. Stryker
    • 17.1.4.1. Overview
    • 17.1.4.2. Product Portfolio
    • 17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.4.4. Sales Footprint
    • 17.1.4.5. Strategy Overview
      • 17.1.4.5.1. Marketing Strategy
      • 17.1.4.5.2. Product Strategy
      • 17.1.4.5.3. Channel Strategy
  • 17.1.5. Zoll Medical Corporation
    • 17.1.5.1. Overview
    • 17.1.5.2. Product Portfolio
    • 17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.5.4. Sales Footprint
    • 17.1.5.5. Strategy Overview
      • 17.1.5.5.1. Marketing Strategy
      • 17.1.5.5.2. Product Strategy
      • 17.1.5.5.3. Channel Strategy
  • 17.1.6. Biotronik
    • 17.1.6.1. Overview
    • 17.1.6.2. Product Portfolio
    • 17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.6.4. Sales Footprint
    • 17.1.6.5. Strategy Overview
      • 17.1.6.5.1. Marketing Strategy
      • 17.1.6.5.2. Product Strategy
      • 17.1.6.5.3. Channel Strategy
  • 17.1.7. Nihon Kohden Corporation
    • 17.1.7.1. Overview
    • 17.1.7.2. Product Portfolio
    • 17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.7.4. Sales Footprint
    • 17.1.7.5. Strategy Overview
      • 17.1.7.5.1. Marketing Strategy
      • 17.1.7.5.2. Product Strategy
      • 17.1.7.5.3. Channel Strategy
  • 17.1.8. METRAWATT International
    • 17.1.8.1. Overview
    • 17.1.8.2. Product Portfolio
    • 17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.8.4. Sales Footprint
    • 17.1.8.5. Strategy Overview
      • 17.1.8.5.1. Marketing Strategy
      • 17.1.8.5.2. Product Strategy
      • 17.1.8.5.3. Channel Strategy
  • 17.1.9. Datrend Systems
    • 17.1.9.1. Overview
    • 17.1.9.2. Product Portfolio
    • 17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.9.4. Sales Footprint
    • 17.1.9.5. Strategy Overview
      • 17.1.9.5.1. Marketing Strategy
      • 17.1.9.5.2. Product Strategy
      • 17.1.9.5.3. Channel Strategy
  • 17.1.10. Fluke
    • 17.1.10.1. Overview
    • 17.1.10.2. Product Portfolio
    • 17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.10.4. Sales Footprint
    • 17.1.10.5. Strategy Overview
      • 17.1.10.5.1. Marketing Strategy
      • 17.1.10.5.2. Product Strategy
      • 17.1.10.5.3. Channel Strategy
  • 17.1.11. BC Group International
    • 17.1.11.1. Overview
    • 17.1.11.2. Product Portfolio
    • 17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.11.4. Sales Footprint
    • 17.1.11.5. Strategy Overview
      • 17.1.11.5.1. Marketing Strategy
      • 17.1.11.5.2. Product Strategy
      • 17.1.11.5.3. Channel Strategy
  • 17.1.12. Netech
    • 17.1.12.1. Overview
    • 17.1.12.2. Product Portfolio
    • 17.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
    • 17.1.12.4. Sales Footprint
    • 17.1.12.5. Strategy Overview
      • 17.1.12.5.1. Marketing Strategy
      • 17.1.12.5.2. Product Strategy
      • 17.1.12.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

관련자료